Related Experiment Video
Updated: Mar 30, 2026
11:56
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
14.8K
Lipophilic vancomycin aglycon dimer with high activity against vancomycin-resistant bacteria
Venkateswarlu Yarlagadda1, Paramita Sarkar1, Goutham B Manjunath1
1Chemical Biology and Medicinal Chemistry Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur PO, Bengaluru 560064, Karnataka, India.
Bioorganic & Medicinal Chemistry Letters
|November 4, 2015
Summary
New vancomycin dimers combat antibiotic-resistant superbugs. A modified dimer showed 300-fold higher activity against vancomycin-resistant Enterococci (VRE), offering a promising strategy to fight resistant bacterial infections.
Area of Science:
- Medicinal Chemistry
- Microbiology
- Drug Discovery
Background:
- Antibiotic resistance, particularly vancomycin-resistant Enterococci (VRE), poses a significant global health threat.
- Existing treatments are becoming less effective against emerging resistant bacterial strains.
Purpose of the Study:
- To synthesize vancomycin aglycon dimers to investigate the influence of linker modifications on antibacterial activity.
- To develop novel compounds effective against antibiotic-resistant bacteria.
Main Methods:
- Synthesis of vancomycin aglycon dimers with varying linker structures.
- Evaluation of antibacterial activity against VRE and Staphylococci.
- Assessment of binding affinity to target peptides and inhibition of peptidoglycan biosynthesis.
Main Results:
- A vancomycin dimer with a lipophilic moiety in the linker demonstrated approximately 300-fold increased activity against VRE compared to vancomycin.
- Enhanced binding affinity to target peptides was observed for the active dimer.
- Improved inhibition of peptidoglycan biosynthesis correlated with increased antibacterial potency.
Conclusions:
- Vancomycin aglycon dimers, particularly those with specific linker modifications, represent a promising class of compounds for combating vancomycin-resistant bacterial infections.
- Facile synthetic methods allow for the preparation of these potent antibacterial agents.
- Further development of these compounds could provide a vital new tool against the growing threat of antibiotic resistance.
Keywords:
Antibacterial activityAntibiotic resistanceCell wall biosynthesis inhibitionVancomycinVancomycin-resistant bacteriaMore Related Videos
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
58
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
58
01:28Antimicrobial Effectiveness
2.0K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.0K
01:25Clinical Significance of Antibiotic Resistance
33
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
33
01:25Inhibitors of Bacterial Protein Synthesis
46
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
46
01:25Mechanism of Antibiotic Resistance in MRSA
99
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
99
01:15Antifungal Agents
42
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
42